N

Novozymatic (Private limited company)

BE 0761.771.979 Active ●Kasteeldreef 38, 2950 Kapellen

Novozymatic is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0761.771.979. It was founded on 19-01-2021. Its registered office is in Kapellen. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € -352 246 and a loss of € 98 442. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 17-10-2026.

Company information

Status
Active
Enterprise number
BE 0761.771.979
VAT registered
Yes
Founded
19-01-2021
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Kasteeldreef 38, 2950 Kapellen
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21100 Fabrication de produits pharmaceutiques de base
21201 Fabrication de médicaments
46460 Commerce de gros de produits pharmaceutiques et médicaux
64210 Activités de société holding
70200 Activités de conseil pour les affaires et autre conseil de gestion
82100 Activités de service de bureau et de soutien administratif

Key figures of Novozymatic

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -98 442+11 %€ -110 982+51 %€ -224 342-38 %€ -162 686
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -352 246-39 %€ -253 804-78 %€ -142 822€ 81 520
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 148 440-40 %€ 247 578+18 %€ 209 406+155 %€ 82 056
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -55 561+27 %€ -76 033+64 %€ -209 664-30 %€ -161 278
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
Janssen Pharmaceutica 2340 Beerse
PFIZER MANUFACTURING BELGIUM 2870 Puurs-Sint-Amands
Organon Heist 2220 Heist-op-den-Berg
Kaneka Belgium 2260 Westerlo
DE CEUSTER MESTSTOFFEN 2280 Grobbendonk
CAPSUGEL BELGIUM 2880 Bornem
MEDICA 2550 Kontich
Novartis Manufacturing 2870 Puurs-Sint-Amands
Looking for more information about Novozymatic?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Novozymatic still active? Yes. The Crossroads Bank for Enterprises lists Novozymatic as active.

What is the VAT number of Novozymatic? The VAT number of Novozymatic is BE 0761.771.979.

When was Novozymatic founded? Novozymatic was founded on 19-01-2021.

What is the address of Novozymatic? The current registered office of Novozymatic is Kasteeldreef 38, 2950 Kapellen.

When did Novozymatic last file annual accounts? The latest annual accounts of Novozymatic were filed on 06-07-2026.

Does Novozymatic file its annual accounts on time? Yes. Novozymatic filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is Novozymatic financially healthy? Addrly gives Novozymatic a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Novozymatic profitable? The annual accounts of Novozymatic for 2025 show a loss of € 98 442.

What is the equity of Novozymatic? The equity of Novozymatic was € -352 246 at the close of the 2025 financial year.

Who are the directors of Novozymatic? The annual accounts of Novozymatic record 1 mandate. The name, role and dates are visible with a free account.

Can Novozymatic receive Peppol e-invoices? Yes. Novozymatic is registered on the Peppol network and can receive structured electronic invoices.

What does Novozymatic do? The main activity of Novozymatic is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data